Rare
lephants
Screener
Toggle theme
LIGAND PHARMACEUTICALS INCORPORATED
LGNXZ
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
Total Cash from Operations:
$288.1M
Line Item
Value
% of Total
Stock Repurchases
$78.0M
27.1%
Other Financing
$208.2M
72.3%
Working Capital
$1.8M
0.6%
Download CSV
